Changing metrics when you dislike the results
Kaiser reacts to New York Governer's attempt to re-define what counts as a Covid-19 case.
Bias
Further adventures of case-counting windows
Kaiser discusses several observations from the Israel booster study.
Primer on Regression Adjustments 1
Kaiser starts a series of posts about regression adjustments.
Real-world studies: limits of knowledge
Kaiser focuses attention on a few aspects of the Mayo Clinic real-world effectiveness study.
A testing mess across the pond
Kaiser takes a glance at the A-Levels controversy in the U.K.
The shift to antibody testing is a choice of death over life
Kaiser looks at the ins and outs of antibody testing.